|
Press Releases |
|
 |
|
Friday, May 7, 2021 |
|
아방스 클리니컬, 174억 달러 규모 시장 수요를 충족하는 유전 기술 임상 시험 서비스 확대 |
호주의 바이오테크 임상수탁기관(CRO) 선두주자이자 프로스트&설리번(Frost & Sullivan)이 수여하는 아시아-태평양 CRO 마켓 리더십 어워드(Asia-Pacific CRO Market Leadership Award)를 수상한 바 있는 아방스 클리니컬은 2023년까지 174억 달러 규모로 증가할 것으로 예상되는 글로벌 수요를 충족할 수 있도록 유전 기술 임상 시험 서비스를 확대해 왔다. more info >> |
|
Avance Clinical Expands Gene Technology Clinical Trial Services to Meet $17.4 billion Market Demand |
The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award winner, Avance Clinical, has expanded its gene technology clinical trial services to meet the increasing global demand predicted to reach $17.4 billion by 2023. more info >> |
|
Friday, April 23, 2021 |
|
Avance Clinical社がOracle Health Sciences Connectで「Decentralized Trials - No Going Back」と題した講演に招待されました |
オーストラリアを代表するバイオテクノロジー企業向けCROであり、フロスト&サリバン社のアジア太平洋CROマーケット・リーダーシップ・アワードを受賞したアヴァンス・クリニカルは、オラクル・ヘルス・サイエンス・コネクト・カンファレンスに招待され、分散型臨床試験の未来について発表しました。 more info >> |
|
아방스 클리니컬, 오라클 헬스 사이언스 커넥트에 초청되어 "분산형 실험 - 이전으로 돌아갈 수 없는 획기적 발전" 발표 |
호주의 바이오테크 임상수탁기관(CRO)선두주자이자 프로스트&설리번(Frost & Sullivan)이 수여하는 아시아태평양 CRO 마켓 리더십 어워드(Asia-Pacific CRO Market Leadership Award)를 수상한 바 있는 아방스 클리니컬은 오라클 헬스 사이언스 커넥트 컨퍼런스에 초청받아 분산형 임상실험(decentralized clinical trials, DCT)의 미래에 대해 발표했다. more info >> |
|
Thursday, April 22, 2021 |
|
Avance Clinical受邀發表“分散試驗–不再回頭” 適用於Oracle Health Sciences Connect |
澳大利亞領先的生物技術CRO和Frost&Sullivan亞太CRO市場領導獎獲得者Avance Clinical已應邀在Oracle Health Sciences Connect會議上介紹了分散臨床試驗的未來。 more info >> |
|
Avance Clinical受邀发表“分散试验–不再回头” 适用于Oracle Health Sciences Connect |
澳大利亚领先的生物技术CRO和Frost&Sullivan亚太CRO市场领导奖获得者Avance Clinical已应邀在Oracle Health Sciences Connect会议上介绍了分散临床试验的未来。 more info >> |
|
Avance Clinical Invited to Present "Decentralized Trials - No Going Back" for Oracle Health Sciences Connect |
The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award winner Avance Clinical has been invited to present on the future of decentralized clinical trials at the Oracle Health Sciences Connect conference. more info >> |
|
Friday, March 12, 2021 |
|
Avance臨床客戶Atossa Therapeutics宣布了第一階段臨床研究的最終結果,該研究表明針對COVID-19研發的AT-301鼻噴霧劑的安全性和耐受性 |
澳大利亞領先的生物技術CRO和Frost&Sullivan亞太CRO市場領導獎獲得者Avance Clinical祝賀Atossa Therapeutics宣布了他們為COVID-19開發的AT-301鼻噴霧劑的第一階段最終結果。 more info >> |
|
Avance临床客户Atossa Therapeutics宣布了第一阶段临床研究的最终结果,该研究表明针对COVID-19研发的AT-301鼻喷雾剂的安全性和耐受性 |
more info >> |
|
Avance Clinical Client Atossa Therapeutics Announces Final Results from Phase 1 Clinical Study Showing Safety and Tolerability of AT-301 Nasal Spray Being Developed for COVID-19 |
The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award winner Avance Clinical congratulated Atossa Therapeutics on the announcement of their Phase 1 final results for the AT-301 nasal spray being developed for COVID-19. more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
調味品龍頭來襲!海天味業啟動港股招股
Jun 13, 2025 23:14 HKT/SGT
|
|
|
调味品龙头来袭!海天味业启动港股招股
Jun 13, 2025 23:02 HKT/SGT
|
|
|
SAP商業AI持續釋放數據價值 驅動企業韌性增長
Jun 13, 2025 22:52 HKT/SGT
|
|
|
Tat Hong Equipment Service Co., Ltd. Announces 2024/25 Annual Results
Jun 13, 2025 21:49 HKT/SGT
|
|
|
達豐設備服務有限公司公佈2024/25全年業績
Jun 13, 2025 21:38 HKT/SGT
|
|
|
达丰设备服务有限公司公布2024/25全年业绩
Jun 13, 2025 21:34 HKT/SGT
|
|
|
Yee Hop Holdings (1662.HK) Subsidiary APEL Launches Microfactory in Collaboration with HKPC
Jun 13, 2025 20:38 HKT/SGT
|
|
|
義合控股(1662.HK)附屬APEL與生產力局攜手打造智能微工廠正式投產
Jun 13, 2025 20:20 HKT/SGT
|
|
|
义合控股(1662.HK)附属APEL与生产力局携手打造智能微工厂正式投产
Jun 13, 2025 19:42 HKT/SGT
|
|
|
Jacobson Pharma Announces FY2025 Annual Results
Jun 13, 2025 19:16 HKT/SGT
|
|
|
雅各臣公佈二零二五財年全年業績 持續經營業務溢利飈升43.1%至3.0億港元
Jun 13, 2025 19:06 HKT/SGT
|
|
|
Desert Mirage or Musical Revolution? ESCAPE Records' Secret Vault Opens, Revealing a Hidden Sonic Sanctuary
Jun 13, 2025 19:00 HKT/SGT
|
|
|
雅各臣公布二零二五财年全年业绩 持续经营业务溢利飙升43.1%至3.0亿港元
Jun 13, 2025 18:53 HKT/SGT
|
|
|
第八届贸发局「创业快綫」10间优胜初创诞生
Jun 13, 2025 16:38 HKT/SGT
|
|
|
第八屆貿發局「創業快綫」10間優勝初創誕生
Jun 13, 2025 15:53 HKT/SGT
|
|
|
|
More News >> |
|
|
|
|
|